Cite
Nalbandian M, Zhao M, Sasaki-Honda M, et al. Characterization of hiPSC-Derived Muscle Progenitors Reveals Distinctive Markers for Myogenic Cell Purification Toward Cell Therapy. Stem Cell Reports. 2021;16(4):883-898doi: 10.1016/j.stemcr.2021.03.004.
Nalbandian, M., Zhao, M., Sasaki-Honda, M., Jonouchi, T., Lucena-Cacace, A., Mizusawa, T., Yasuda, M., Yoshida, Y., Hotta, A., & Sakurai, H. (2021). Characterization of hiPSC-Derived Muscle Progenitors Reveals Distinctive Markers for Myogenic Cell Purification Toward Cell Therapy. Stem cell reports, 16(4), 883-898. https://doi.org/10.1016/j.stemcr.2021.03.004
Nalbandian, Minas, et al. "Characterization of hiPSC-Derived Muscle Progenitors Reveals Distinctive Markers for Myogenic Cell Purification Toward Cell Therapy." Stem cell reports vol. 16,4 (2021): 883-898. doi: https://doi.org/10.1016/j.stemcr.2021.03.004
Nalbandian M, Zhao M, Sasaki-Honda M, Jonouchi T, Lucena-Cacace A, Mizusawa T, Yasuda M, Yoshida Y, Hotta A, Sakurai H. Characterization of hiPSC-Derived Muscle Progenitors Reveals Distinctive Markers for Myogenic Cell Purification Toward Cell Therapy. Stem Cell Reports. 2021 Apr 13;16(4):883-898. doi: 10.1016/j.stemcr.2021.03.004. Epub 2021 Apr 01. PMID: 33798449; PMCID: PMC8072070.
Copy
Download .nbib